LSX Nordic Congress

🚀 The Nordic life sciences event of the year is happening today! The LSX Nordic Congress kicks off 19-20 May 2026 at the Radisson Blu Scandinavia Hotel in Copenhagen, and it's where the region's most groundbreaking deals, partnerships, and investments come to life. Here's what's waiting for you: 🤝 Qualified 1:1 Partnering - Connect directly with top-tier VCs, family offices, corporate venture arms, and senior BD&L teams actively seeking Seed to Series B opportunities 💡 400+ Senior Decision-Makers - Network with CEOs, investors, R&D leaders, and industry KOLs from biotech, medtech, and healthtech across the Nordic region 🎯 Strategic Pitch Sessions - Showcase your innovation to investors who are ready to fund the next healthcare revolution 🌍 Nordic Innovation Hub - Gain exclusive insights into the thriving Copenhagen biotech ecosystem and forge partnerships that accelerate your path from innovation to market 👉 Full details: https://lnkd.in/eCkHc4Rq #LSXNordic #LifeSciences #Biotechnology #Medtech #HealthTech #NordicInnovation

🚀 Unlocking Capital in the Nordics: A Medtech Funding Masterclass Securing investment in the Nordic region requires a fundamentally different approach than traditional Silicon Valley models. The landscape here is characterised by boutique investment firms, extended evaluation periods, and distinctive regional considerations—demanding innovative thinking from founders navigating their growth journey. We're bringing together industry experts to share proven strategies and real-world experiences from the Nordic medtech ecosystem. 🔍 What We'll Explore: • How Nordic venture capital firms evaluate opportunities and structure deals • Maximising public funding programmes and grant opportunities • Transforming founder mentality for sustainable growth • Diversifying your capital stack with venture debt, crowdfunding, and beyond 👥 Featured Speakers: • Stina Wallmark, Investment Director, Life Sciences, Voima Ventures • Virpi Muhonen, CEO, Askel Healthcare • Sergio Ferreira, Head of Funding, Norway Health Tech • Svana Gunnarsdottir, Founding Partner, Frumtak Ventures • Johanna Asklin, General Partner, Fåhraeus Startup & Growth 📆 Date: 19-20 May 2026 🏨 Venue: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Register and discover more: https://lnkd.in/eaqWizDY This is your chance to learn practical strategies and network with the innovators driving Nordic medtech forward! Connect with peers, gain expert perspectives, and leave with actionable takeaways. 💡 #LSXNordic #medtech #medicaldevices #healthtech #digitalhealth

🚀 The Future of Cancer Treatment is Being Written in the Nordics 🚀 Across Scandinavia, a powerful convergence of cutting-edge research, robust healthcare infrastructure, and cross-sector partnerships is revolutionising how we approach cancer care. The Nordic region stands as a beacon of oncology advancement, pioneering developments in targeted therapies, immunological treatments, and diagnostic innovation that promise to reshape patient outcomes globally. 🔬 What We'll Explore: • Groundbreaking cancer research and therapeutic developments from Scandinavian innovators • How targeted treatment approaches and immune-based therapies are transforming patient care • Building bridges between research institutions, pharmaceutical innovators, and clinical practitioners • Overcoming barriers in trial accessibility, regulatory frameworks, and ensuring cancer care equity across populations 🎙️ Hear From Industry Leaders: • Torquil Jackson, Investment Manager, Cancer Research Horizons • Cristiana Pires, CEO, Asgard Tx • Per Andersson, CEO, Xspray Pharma • Tobias Todsen, Co-Founder & CMO, 3Sonic • Oystein Soug, CEO, Oncoinvent 📆 Date: 19-20 May 2026 🏨 Venue: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Review the full programme: https://lnkd.in/eZKMJYxp Be part of the conversation shaping tomorrow's oncology landscape and witness how Nordic innovation is making a global impact in the fight against cancer! 🌍

🌟 Open the Window: Is the Medtech IPO Market Back Open? The medtech IPO market is showing signs of recovery after years of dormancy, with 2025 delivering notable public offerings and renewed investor appetite. But timing remains critical as companies balance market conditions, regulatory landscapes, and investor expectations. This panel of experts discuss the current IPO environment, what's driving the recovery, and strategic considerations for medtech companies planning public offerings in the next 18 months. 💡 Key Discussion Points: • Reviewing the IPO landscape • The relevance of European public markets against the US • Revenue thresholds, profitability paths and growth metrics for going public • IPO vs M&A vs continued private growth 🎤 Featured Speakers: • Josefine Persson, Associate, HealthCap • Torbjørn Furuseth, CEO & Co-Founder, DoMore Diagnostic • Bibi Sattar Marques, Partner, Buenavista Equity Partners • Peter Legind-Hansen, Director, Global Listing Services - Nordics, Nasdaq Copenhagen 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/eKFyMhb8 #LSXNordic #MedTech #HealthTech #IPO

🌟 From the Drawing Board to the Hospital: Why You Need Clinicians in Your Team The graveyard of failed medical devices is littered with brilliant technologies that never integrated into actual clinical workflows. While technical innovation captures headlines, the real success factor lies in understanding the human side of healthcare delivery, something only clinicians truly grasp. This panel features entrepreneurs, implementation experts, and investors to reveal why clinician involvement from day one isn't just helpful, it's essential for sustainable adoption. 💡 Key Discussion Points: • Designing tech for real-world healthcare delivery • Building physician champions and overcoming clinical resistance • User experience design for time-pressured healthcare environments • Measuring implementation success beyond technical metrics 🎤 Featured Speakers: • Magnus Klaesson, Co-Founder & Chairman of the Board, Life Science Invest AB • Rebecca Love RN, MSN, FIEL, Chief Clinical Officer, Quadrivia AI • Catherine Boule, Managing Partner, Karista • Malin Frithiofsson, Co-founder & CEO, Daya Ventures 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/eS9wZHqV #LSXNordic #MedTech #HealthTech

🌟 Get Paid: Nordic Reimbursement Strategies for Medtech and Healthtech Startups Reimbursement remains the ultimate make-or-break factor for medtech and digital health startups, with Nordic healthcare systems offering both unique opportunities through universal coverage and complex challenges through centralized decision-making. Our panel will discuss strategies for effective reimbursement in the Nordics with real-life case studies. 💡 Key Discussion Points: • Health Technology Assessment requirements across Nordic countries • Building compelling health economics cases with limited real-world data • Timing reimbursement applications with clinical evidence generation 🎤 Featured Speakers: • Nicolas Bouchet, Investment Manager, Health Tech Hub Copenhagen • Martin Stenfeldt, CEO, UNEEG Medical A/S • Ruth Brännvall,CEO and General Partner, Impact Invest Scandinavia • Laurent Pacheco, MD PhD MBA FFPM GFMD, Managing Partner, International Family Offices Alliance for Health 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/ecKwac9R #LSXNordic #MedTech #HealthTech

🌟 Oncology Spotlight – Advancing Cancer Care in the Nordics 🌟 The Nordics are at the forefront of oncology innovation, leveraging world-class healthcare systems, advanced research institutions, and a collaborative ecosystem to transform cancer care. From breakthroughs in immunotherapy and precision medicine to early detection technologies, the region is shaping the future of cancer treatment. 💡 Key Discussion Points: • Promising oncology innovations emerging from the Nordic region • Leveraging precision medicine and immunotherapy to improve cancer outcomes • The critical role of collaboration between academia, biotech companies, and healthcare providers • Addressing challenges like access to clinical trials, regulatory hurdles, and equitable cancer care 🎤 Featured Speakers: • Mai-Britt Zocca, CEO, IO Biotech • Cristiana Pires, CEO, Asgard Tx • Per Andersson, CEO, Xspray Pharma • Tobias Todsen, Co-Founder & CMO, 3Sonic • Oystein Soug, CEO, Oncoinvent 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/eZKMJYxp Join us to explore how the Nordics are driving the future of oncology innovation and improving lives worldwide! 🚀

🔥 Fireside Chat: Same Game, New Players – Can EUMDR Keep Pace with AI-Driven Medtech Innovation? 🔥 AI and software-driven medtech are revolutionising healthcare, but can the EUMDR framework keep up? Designed for traditional medical devices, the regulations are being tested by adaptive algorithms, continuous learning systems, and rapid innovation cycles. This fireside chat will bring together regulatory experts, AI medtech founders, and investors to explore the challenges and opportunities of navigating MDR compliance in the age of AI. 💡 Key Discussion Points: • Classifications for software as a medical device and clinical decision support systems • Managing continuous learning algorithms and post-market surveillance under MDR • Clinical evidence requirements for AI systems • Harmonization challenges across EU member states for digital health 🎤 Featured Speakers: • Jesper Grønbæk, Founder & CEO, Health Tech Hub Copenhagen • Alejo Costa Ribalta, Partner, CRB Health Tech SGEIC 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/ewcyvYhz Join us to explore how regulations must evolve to keep pace with AI-driven medtech innovation! 🚀

🌟 Panel Discussion Spotlight: Beyond the Horizon – Next-Generation GLP-1s and the Future of Diabetes Care 🌟 GLP-1 receptor agonists have revolutionized diabetes care, delivering remarkable results in glycemic control, weight management, and cardiovascular health. But the journey doesn’t stop here. Next-generation GLP-1 therapies are set to redefine the field with innovative delivery systems, extended half-lives, and combination approaches targeting broader metabolic disorders. Join us for an in-depth discussion on the transformative potential of these therapies and the challenges of bringing them to patients worldwide. 💡 Key Discussion Points: • Transforming diabetes and metabolic disorder treatments with next-generation GLP-1 therapies • Overcoming regulatory, manufacturing, and accessibility challenges for GLP-1 therapies • Expanding GLP-1 applications beyond diabetes to address obesity, NASH, and cardiovascular disease 🎤 Featured Speakers: • Kasper Wickzén, CCO, Sigrid Therapeutics • Gustav Hanghøj Gram, CEO, Pila Pharma • Hamza Bokhari, Executive Director - Preclinical Strategy & Business Development, Atrogi AB 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/euCHhZ4k Be part of the conversation shaping the future of diabetes care and metabolic health! 🚀

🌟 Panel Discussion Highlight: From Fjords to Fortune – Nordic Medtech Companies Conquering the US Market 🌟 Expanding into the US, the world's largest medtech market, presents Nordic companies with unique challenges and opportunities. From navigating FDA regulations and reimbursement complexities to building culturally integrated teams and accessing US venture capital, this panel will provide actionable insights for medtech leaders looking to succeed across the Atlantic while staying true to their Nordic roots. 💡 Key Discussion Points: • Crafting a business model tailored for the US market • Navigating reimbursement, IP, and regulatory hurdles for expansion • Building and integrating teams in the US: hiring, compensation, and cultural challenges • Unlocking the importance of US venture capital for growth 🎤 Featured Speakers: • Jonas Jendi, Senior Investment Director & Life Science Practice Lead, Industrifonden • Jørn Emborg, Senior Advisor, Innovation Centre Denmark Boston • Robert Smith, Founder & CEO, Conscious Capital 📅 When: May 19-20, 2026 📍 Where: Radisson Blu Scandinavia Hotel, Copenhagen, Denmark 🔗 Learn more and register here: https://lnkd.in/e7-D7hbm Join us to explore how Nordic medtech companies are conquering the US market and driving global innovation! 🚀